Immunocore Holdings plc

From Immunocore's results release of 6 Kasım 2026; its quarterly report has since been filed.

• Revenue

  Actual

  $102,2M

  -%1,4 y/y ↓
  -%12 q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  -$0,28

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  -$13,6M

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.